NEW: Highlights from GEM 2024... more
Pf7: An open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples
16 Jan 2023

MalariaGEN et. al

Wellcome Open Research, 2023; 8 22 DOI: 10.12688/wellcomeopenres.18681.1

Parasite

About the Plasmodium falciparum version 7 data

This page provides information about the Pf7 dataset which contains genome variation data on over 20,000 worldwide samples of Plasmodium falciparum. The key publication is MalariaGEN et al, Wellcome Open Research 2023, 8:22 https://doi.org/10.12688/wellcomeopenres.18681.1.

Open the Pf7 app to view summary information about contributing studies, countries, and resistance profiles.

Background and previous releases

This dataset is based on genome variation from the MalariaGEN network, including samples which were previously released through the Pf3k Project, Plasmodium falciparum Community Project and GenRe Mekong Project. It comprises multiple partner studies, each with its own research objectives and led by a local investigator. Genome sequencing is performed centrally, and partner studies are free to analyse and publish the genetic data produced on their own samples, in line with MalariaGEN’s guiding principles on equitable data sharing.

This new open dataset is almost three times larger than the last dataset release (Pf6, published 2021), and includes samples from a wider geographic reach. The variants and genotypes described in this publication used version 3 of the analysis pipeline. Data produced using an earlier version of the data analysis pipeline can be explored using an interactive web application.

About the version 7 data pipeline

Details of the methods can be found in the accompanying paper and here.

Content of the data release

This release contains details on contributing partner studies, sample metadata and key sample attributes inferred from genomic data, and genomic data including raw sequence reads. Further details and analytical results can be found in the accompanying data release paper.

These data are available open access. Publications using these data should acknowledge and cite the source of the data using the following format: “This publication uses MalariaGEN data as described in ‘Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples’ MalariaGEN et al, Wellcome Open Research 2023, 8:22 https://doi.org/10.12688/wellcomeopenres.18681.1.

  • Study information: Details of the 82 contributing partner studies, including description, contact information and key people.
  • Sample provenance and sequencing metadata: sample information including partner study information, location and year of collection, ENA accession numbers, and QC information for 20,864 samples from 33 countries.
  • Measure of complexity of infections: characterisation of within-host diversity (FWS) for 16,203 QC pass samples.
  • Drug resistance marker genotypes: genotypes at known markers of drug resistance for 16,203 samples, containing amino acid and copy number genotypes at six loci: crt, dhfr, dhps, mdr1, kelch13, plasmepsin 2-3.
  • Inferred resistance status classification: classification of 16,203 QC pass samples into different types of resistance to 10 drugs or combinations of drugs and to RDT detection: chloroquine, pyrimethamine, sulfadoxine, mefloquine, artemisinin, piperaquine, sulfadoxine- pyrimethamine for treatment of uncomplicated malaria, sulfadoxine- pyrimethamine for intermittent preventive treatment in pregnancy, artesunate-mefloquine, dihydroartemisinin-piperaquine, hrp2 and hrp3 gene deletions.
  • Drug resistance markers to inferred resistance status: details of the heuristics utilised to map genetic markers to resistance status classification.
  • CRT haplotypes: Full crt gene haplotypes for 16,203 QC pass samples. These are available at ftp://ngs.sanger.ac.uk/production/malaria/Resource/34/Pf7_crt_haplotypes.txt
  • CSP C-terminal haplotypes: Full csp C-terminal haplotypes for 16,203 QC pass samples plus 6 lab strains. These are available at ftp://ngs.sanger.ac.uk/production/malaria/Resource/34/Pf7_csp_c_terminal_haplotypes.txt
  • EBA175 calls: eba175 allelic type calls for 16,203 QC pass samples.
  • Reference genome: the version of the 3D7 reference genome fasta file used for mapping. This is available at ftp://ngs.sanger.ac.uk/production/malaria/Resource/34/Pfalciparum.genome.fasta
  • Annotation file: the version of the 3D7 reference annotation gff file used for genome annotations. This is available at ftp://ngs.sanger.ac.uk/production/malaria/Resource/34/Pfalciparum_replace_Pf3D7_MIT_v3_with_Pf_M76611.gff
  • Genetic distances: Genetic distance matrix comparing all 20,864 samples. This is available at ftp://ngs.sanger.ac.uk/production/malaria/Resource/34/Pf7_genetic_distance_matrix.npy
  • Short variants genotypes: Genotype calls on 10,145,661 SNPs and short indels in all 20,864 samples from 33 countries, available both as VCF (ftp://ngs.sanger.ac.uk/production/malaria/Resource/34/Pf7_vcf/) and zarr (ftp://ngs.sanger.ac.uk/production/malaria/Resource/34/Pf7.zarr.zip) files.

A README file describes in fine detail all the files included in the release, the format and interpretation of each column, and contains some tips and tricks for accessing genotype data in VCF and zarr files.

NOTE: You may need to download a free FTP client to access the FTP links.

The Pf7 user guide is a useful companion to these data, providing information on how to use the malariagen_data Python package to access data in the cloud using free computer services and Jupyter Notebooks without having to first download the resource locally.

Additional files that have been released since the initial data release are listed below.

  • Deletion and breakpoint locations with the histidine-rich protein genes II and III (HRP-2 and -3): List of deletion and breakpoint locations within the histidine-rich protein genes II and III (HRP-2 and -3) across 16,203 QC-pass samples. All samples with a deletion either have an exact breakpoint (in the case of samples where the deletion is due to telomere healing) or a breakpoint range (in the case of recombination with a different chromosome that has similar sequence).
  • Mean pairwise FST between all major sub-populations
  • Bam and gvcf files for all samples: Bam files are the final sample-level bams created as part of the pipeline. These differ in a number of ways from the raw bam/cram files available at the ENA. For example we have remapped all reads to the latest reference genome, fixed mates and marked duplicates, run GATK’s BQSR and merged lanes where a sample had more than one lane of sequencing data. Gvcf files are the output of GATK’s HaplotypeCaller. This could be useful if you would like to create a joint call set of Pf7 and your own sequencing data.

Supplementary data

The following supplementary data is available as a single document download: Supplementary data

  • Supplementary Table 1. Breakdown of analysis set samples by geography
  • Supplementary Table 2. Studies contributing samples
  • Supplementary Table 3. Summary of discovered variant positions
  • Supplementary Table 4. Numbers of samples used to determine proportions in Table 2.
  • Supplementary Table 5. Newly emerging Dd2 background mutations in crt.
  • Supplementary Table 6. Frequency of HRP2 and HRP3 deletions by country.
  • Supplementary Table 7. Summary of hrp2 and hrp3 deletion breakpoints.
  • Supplementary Figure 1. Breakdown of samples by country.
  • Supplementary Figure 2. Distribution of samples by year of collection.
  • Supplementary Figure 3. Lack of bias in population structure due to use of sWGA.
  • Supplementary Figure 4. Population structure from a neighbour-joining tree.
  • Supplementary Figure 5. Linkage disequilibrium decay in ten major parasite sub-populations.
  • Supplementary Figure 6. Characteristics of the ten major parasite sub-populations.
  • Supplementary Figure 7. Geographic patterns of population differentiation and gene flow.
  • Supplementary Figure 8. Abacus plot of inferred drug resistance frequencies in location/year combinations.
  • Supplementary Figure 9. Increase in frequency of KEL1.
  • Supplementary Figure 10. Variation in c-terminal of csp.
  • Supplementary Figure 11. Proportion of C allele of eba175 in different major sub-populations.

Publications that have used the P. falciparum Community Project data resource, prior to and including version 7

  1. Abera D, Kibet CK, Degefa T, et al. Genomic analysis reveals independent evolution of Plasmodium falciparum populations in Ethiopia. Malar J. 2021; 20 129.
  2. Ajibola O, Diop MF, Ghansah A, et al. In silico characterisation of putative Plasmodium falciparum vaccine candidates in African malaria populations. Sci Rep. 2021 Aug 10;11(1):16215.
  3. Amegashie EA, Amenga-Etego L, Adobor C, et al. Population genetic analysis of the Plasmodium falciparum circumsporozoite protein in two distinct ecological regions in Ghana. Malar J. 2020; 19 437.
  4. Amenga-Etego LN, Asoala V, Agongo G, et al. Temporal evolution of sulfadoxine-pyrimethamine resistance genotypes and genetic diversity in response to a decade of increased interventions against Plasmodium falciparum in northern Ghana. Malar J. 2021; 20 152.
  5. Aninagyei E, Tetteh CD, Oppong M, et al. Efficacy of Artemether-Lumefantrine on various Plasmodium falciparum Kelch 13 and Pfmdr1 genes isolated in Ghana. Parasite Epidemiol Control. 2020 Nov; 11 e00190.
  6. Aniweh Y, Suurbaar J, Morang’a CM, et al. Analysis of Plasmodium falciparum Rh2b deletion polymorphism across different transmission areas. Sci Rep. 2020 Jan 30;10(1):1498.
  7. Band G, Leffler EM, Jallow M, et al. Malaria protection due to sickle haemoglobin depends on parasite genotype. Nature. 2022; 602(7895):106-111.
  8. Battey CJ, Ralph PL, Kern AD. Predicting geographic location from genetic variation with deep neural networks. eLife. 2020; 9 e54507.
  9. Bell GJ, Agnandji ST, Asante KP, et al. Impacts of Ecology, Parasite Antigenic Variation, and Human Genetics on RTS,S/AS01e Malaria Vaccine Efficacy. Curr Epidemiol Rep. 2021 Jul 30:1-10.
  10. Brown TS, Arogbokun O, Buckee CO, et al. Distinguishing gene flow between malaria parasite populations. PLoS Genet. 2021 Dec; 17(12): e1009335.
  11. Bwire GM, Mikomangwa WP, Kilonzi M. Occurrence of septuple and elevated Pfdhfr-Pfdhps quintuple mutations in a general population threatens the use of sulfadoxine-pyrimethamine for malaria prevention during pregnancy in eastern-coast of Tanzania. BMC Infect Dis. 2020; 20 530.
  12. Bwire GM, Ngasala B, Mikomangwa WP, et al. Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania. Sci Rep. 2020; 10 3500.
  13. Calçada C, Silva M, Baptista V, et al. Expansion of a Specific Plasmodium falciparum PfMDR1 Haplotype in Southeast Asia with Increased Substrate Transport. mBio. 2020 Nov-Dec; 11(6) e02093-20.
  14. Carpi G, Gorenstein L, Harkins TT, et al. A GPU-accelerated compute framework for pathogen genomic variant identification to aid genomic epidemiology of infectious disease: a malaria case study. Brief Bioinform. 2022 Sep 20; 23(5):bbac314.
  15. Chaturvedi R, Chhibber-Goel J, Verma I, et al. Geographical spread and structural basis of sulfadoxine-pyrimethamine drug-resistant malaria parasites. Int J Parasitol. 2021 Jun; 51(7):505-525.
  16. Coulibaly A, Diop MF, Kone A, et al. Genome-wide SNP analysis of Plasmodium falciparum shows differentiation at drug-resistance-associated loci among malaria transmission settings in southern Mali. Front Genet. 2022 Oct 4; 13:943445.
  17. Da Veiga Leal S, Ward D, Campino S, et al. Drug resistance profile and clonality of Plasmodium falciparum parasites in Cape Verde: the 2017 malaria outbreak. Malar J. 2021; 20 172.
  18. de Jong RM, Meerstein-Kessel L, Da DF, et al. Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoes. NPJ Vaccines. 2021 Aug 12; 6(1):101.
  19. Diallo MA, L’Ollivier C, Diongue K, et al. Spatiotemporal Dynamic of the RTS,S/AS01 Malaria Vaccine Target Antigens in Senegal. Am J Trop Med Hyg. 2021 Oct 11;105(6):1738-1746.
  20. Dimonte S, Bruske EI, Enderes C, et al. Identification of a conserved var gene in different Plasmodium falciparum strains. Malar J. 2020 May 29;19(1):194.
  21. Dumetz F, Chow EY, Harris LM, et al. G-quadruplex RNA motifs influence gene expression in the malaria parasite Plasmodium falciparum. Nucleic Acids Res. 2021 Dec 2; 49(21): 12486-12501.
  22. Feleke SM, Reichert EN, Mohammed H, et al. Plasmodium falciparum is evolving to escape malaria rapid diagnostic tests in Ethiopia. Nat Microbiol. 2021 Oct; 6(10):1289-1299.
  23. Gaye A, Sy M, Ndiaye T, et al. Amplicon deep sequencing of kelch13 in Plasmodium falciparum isolates from Senegal. Malar J. 2020 Mar 30;19(1):134.
  24. Gill J, Sharma A. Genomic analysis of single nucleotide polymorphisms in malaria parasite drug targets. Parasit Vectors. 2022 Aug 30; 15(1):309.
  25. Grignard L, Nolder D, Sepúlveda N, et al. A novel multiplex qPCR assay for detection of Plasmodium falciparum with histidine-rich protein 2 and 3 (pfhrp2 and pfhrp3) deletions in polyclonal infections. EBioMedicine. 2020 May; 55 102757.
  26. Hamaluba M, van der Pluijm RW, Weya J, et al. Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial. Lancet Infect Dis. 2021 Oct; 21(10): 1395-1406.
  27. Han J, Munro JE, Kocoski A, et al. Population-level genome-wide STR discovery and validation for population structure and genetic diversity assessment of Plasmodium species. PLoS Genet. 2022 Jan 10; 18(1):e1009604.
  28. Huang HY, Liang XY, Lin LY, et al. Genetic polymorphism of Plasmodium falciparum circumsporozoite protein on Bioko Island, Equatorial Guinea and global comparative analysis. Malar J. 2020; 19 245.
  29. Hussien M, Abdel Hamid MM, Elamin EA, et al. Antimalarial drug resistance molecular makers of Plasmodium falciparum isolates from Sudan during 2015-2017. PLoS One. 2020; 15(8) e0235401.
  30. Imwong M, Dhorda M, Myo Tun K, et al. Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study. Lancet Infect Dis. 2020 Dec;20(12):1470-1480.
  31. Jacob CG, Thuy-Nhien N, Mayxay M, et al. Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination. Elife. 2021 Aug 10; 10:e62997.
  32. Jones S, Subramaniam G, Plucinski MM, et al. One-step PCR: A novel protocol for determination of pfhrp2 deletion status in Plasmodium falciparum. PLoS One. 2020; 15(7) e0236369.
  33. Joste V, Guillochon E, Fraering J, et al. PfEMP1 A-Type ICAM-1-Binding Domains Are Not Associated with Cerebral Malaria in Beninese Children. mBio. 2020 Nov-Dec; 11(6) e02103-20.
  34. Kagoro FM; Barnes KI; Marsh K; et al. Mapping genetic markers of artemisinin resistance in Plasmodium falciparum malaria in Asia: a systematic review and spatiotemporal analysis. 2022;3(3):e184-e192.
  35. Keitany GJ, Jenkins BJ, Obiakor HT, et al. An Invariant Protein That Colocalizes With VAR2CSA on Plasmodium falciparum-Infected Red Cells Binds to Chondroitin Sulfate A. J Infect Dis. 2021 Oct 29:jiab550.
  36. Knudson A, González-Casabianca F, Feged-Rivadeneira A, et al. Spatio-temporal dynamics of Plasmodium falciparum transmission within a spatial unit on the Colombian Pacific Coast. Sci Rep. 2020; 10 3756.
  37. Kone A, Sissoko S, Fofana B, et al. Different Plasmodium falciparum clearance times in two Malian villages following artesunate monotherapy. Int J Infect Dis. 2020 Jun; 95 399-405.
  38. Kreutzfeld O, Rasmussen SA, Ramanathan AA, et al. Associations between Varied Susceptibilities to PfATP4 Inhibitors and Genotypes in Ugandan Plasmodium falciparum Isolates. Antimicrob Agents Chemoth. 2021 Sep 17; 65(10):e0077121.
  39. Lee RA, Puig H, Nguyen PQ, et al. Ultrasensitive CRISPR-based diagnostic for field-applicable detection of Plasmodium species in symptomatic and asymptomatic malaria. Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25722-25731.
  40. Lee WC, Russell B, Lee B, et al. Plasmodium falciparum rosetting protects schizonts against artemisinin. EBioMedicine. 2021 Nov; 73:103680.
  41. Letcher B, Hunt M, Iqbal Z. Gramtools enables multiscale variation analysis with genome graphs. Genome Biol. 2021; 22: 259.
  42. Lin LY, Huang HY, Liang XY, et al. Genetic diversity and natural selection on the thrombospondin-related adhesive protein (TRAP) gene of Plasmodium falciparum on Bioko Island, Equatorial Guinea and global comparative analysis. Malar J. 2021; 20 124.
  43. Liu, S, Huckaby, AC, Brown, AC, et al. Single-cell sequencing of the small and AT-skewed genome of malaria parasites. Genome Med. 2021; 13 75.
  44. Li Y, Shetty AC, Lon C, et al. Detecting geospatial patterns of Plasmodium falciparum parasite migration in Cambodia using optimized estimated effective migration surfaces. Int J Health Geogr. 2020; 19 13.
  45. Mackenzie G, Jensen RW, Lavstsen T, Otto TD. Varia: a tool for prediction, analysis and visualisation of variable genes. BMC Bioinformatics. 2022; 23: 52.
  46. Mathieu LC, Cox H, Early AM, et al. Local emergence in Amazonia of Plasmodium falciparum k13 C580Y mutants associated with in vitro artemisinin resistance. eLife. 2020; 9 e51015.
  47. Mbye H, Mane K, Diop MF, et al. Plasmodium falciparum merozoite invasion ligands, linked antimalarial resistance loci and ex vivo responses to antimalarials in The Gambia. J Antimicrob Chemother. 2022; 77(11):2946-2955.
  48. Michelow IC, Park S, Tsai SW, et al. A newly characterized malaria antigen on erythrocyte and merozoite surfaces induces parasite inhibitory antibodies. J Exp Med. 2021 Sep 6; 218(9):e20200170.
  49. Miotto O, Sekihara M, Tachibana SI, et al. Emergence of artemisinin-resistant Plasmodium falciparum with kelch13 C580Y mutations on the island of New Guinea. PLoS Pathog. 2020 Dec; 16(12) e1009133.
  50. Mohamed AO, Hussien M, Mohamed A, et al. Assessment of Plasmodium falciparum drug resistance molecular markers from the Blue Nile State, Southeast Sudan. Malar J. 2020; 19 78.
  51. Molina-Cruz A, Raytselis N, Withers R, et al. A genotyping assay to determine geographic origin and transmission potential of Plasmodium falciparum malaria cases. Commun Biol. 2021; 4: 1145.
  52. Moore AJ, Mangou K, Diallo F, et al. Assessing the functional impact of PfRh5 genetic diversity on ex vivo erythrocyte invasion inhibition. Sci Rep. 2021; 11 2225.
  53. Morgan AP, Brazeau NF, Ngasala B, et al. Falciparum malaria from coastal Tanzania and Zanzibar remains highly connected despite effective control efforts on the archipelago. Malar J. 2020; 19 47.
  54. Moser KA, Madebe RA, Aydemir O, et al. Describing the current status of Plasmodium falciparum population structure and drug resistance within mainland Tanzania using molecular inversion probes. Mol Ecol. 2021 Jan; 30(1):100-113.
  55. Naung MT, Martin E, Munro J, et al. Global diversity and balancing selection of 23 leading Plasmodium falciparum candidate vaccine antigens. PLoS Comput Biol. 2022; 18(2):e1009801.
  56. Ndwiga L, Osoti V, Ochwedo KO, et al. The Plasmodium falciparum Rh5 invasion protein complex reveals an excess of rare variant mutations. Malar J. 2021 Jun 23; 20(1):278.
  57. Omedo I, Bartilol B, Kimani D, et al. Spatio-temporal distribution of antimalarial drug resistant gene mutations in a Plasmodium falciparum parasite population from Kilifi, Kenya: A 25-year retrospective study. Wellcome Open Res 2022, 7:45.
  58. Osborne A, Manko E, Takeda M, et al. Characterizing the genomic variation and population dynamics of Plasmodium falciparum malaria parasites in and around Lake Victoria, Kenya. Sci Rep. 2021; 11: 19809.
  59. Ouattara A, Dwivedi A, Adams M, et al. An In Silico Analysis of Malaria Pre-Erythrocytic-Stage Antigens Interpreting Worldwide Genetic Data to Suggest Vaccine Candidate Variants and Epitopes. Microorganisms. 2022; 10(6):1090.
  60. Paloque L, Coppée R, Stokes BH, et al. Mutation in the Plasmodium falciparum BTB/POZ Domain of K13 Protein Confers Artemisinin Resistance. Antimicrob Agents Chemother. 2022 Jan 18; 66(1):e0132021.
  61. Parr JB, Kieto E, Phanzu F, et al. Analysis of false-negative rapid diagnostic tests for symptomatic malaria in the Democratic Republic of the Congo. Sci Rep. 2021; 11 6495.
  62. Patel PN, Dickey TH, Hopp CS, et al. Neutralizing and interfering human antibodies define the structural and mechanistic basis for antigenic diversion. Nat Commun. 2022 Oct 6; 13(1):5888.
  63. Rawat M, Kanyal A, Choubey D, et al. Identification of Co-Existing Mutations and Gene Expression Trends Associated With K13-Mediated Artemisinin Resistance in Plasmodium falciparum. Front. Genet. 13:824483.
  64. Rawat M, Kanyal A, Choubey D, et al. Identification of Co-Existing Mutations and Gene Expression Trends Associated With K13-Mediated Artemisinin Resistance in Plasmodium falciparum. Front Genet. 2022 Apr 6; 13:824483.
  65. Ray A, Mathur M, Choubey D, et al. Autophagy Underlies the Proteostasis Mechanisms of Artemisinin Resistance in P. falciparum Malaria. mBio. 2022; 13(3):e0063022.
  66. Shah Z, Naung MT, Moser KA, et al. Whole-genome analysis of Malawian Plasmodium falciparum isolates identifies possible targets of allele-specific immunity to clinical malaria. PLoS Genet. 2021 May 25; 17(5):e1009576.
  67. Sharma AI, Shin SH, Bopp S, et al. Genetic background and PfKelch13 affect artemisinin susceptibility of PfCoronin mutants in Plasmodium falciparum. PLoS Genet. 2020 Dec; 16(12) e1009266.
  68. Shi SM, Shi TQ, Chen SB, et al. Genome-Wide Scans for Ghanaian Plasmodium falciparum Genes Under Selection From Local and Chinese Host Populations. Front Cell Infect Microbiol. 2021; 11 630797.
  69. Singh K, Burkhardt M, Nakuchima S, et al. Structure and function of a malaria transmission blocking vaccine targeting Pfs230 and Pfs230-Pfs48/45 proteins. Commun Biol. 2020; 3 395.
  70. Smith EC, Limbach KJ, Rangel N, et al. Novel malaria antigen Plasmodium yoelii E140 induces antibody-mediated sterile protection in mice against malaria challenge. PLoS One. 2020; 15(5) e0232234.
  71. Sookpongthai P, Utayopas K, Sitthiyotha T, et al. Global diversity of the gene encoding the Pfs25 protein – a Plasmodium falciparum transmission-blocking vaccine candidate. Parasit Vectors. 2021; 14: 571.
  72. Stewart LB, Diaz-Ingelmo O, Claessens A, et al. Intrinsic multiplication rate variation and plasticity of human blood stage malaria parasites. Commun Biol. 2020; 3 624.
  73. Sy M, Deme AB, Warren JL, et al. Plasmodium falciparum genomic surveillance reveals spatial and temporal trends, association of genetic and physical distance, and household clustering. Sci Rep. 2022; 12: 938.
  74. Tagliamonte MS, Yowell CA, Elbadry MA, et al. Genetic Markers of Adaptation of Plasmodium falciparum to Transmission by American Vectors Identified in the Genomes of Parasites from Haiti and South America. mSphere. 2020; 5(5):e00937-20.
  75. Tandoh KZ, Amenga-Etego L, Quashie NB, et al. Plasmodium falciparum Malaria Parasites in Ghana Show Signatures of Balancing Selection at Artemisinin Resistance Predisposing Background Genes. Evol Bioinform Online. 2021; 17 1176934321999640.
  76. Tandoh KZ, Amenga-Etego L, Quashie NB, et al. Plasmodium falciparum Malaria Parasites in Ghana Show Signatures of Balancing Selection at Artemisinin Resistance Predisposing Background Genes. Evol Bioinform Online. 2021 Mar 3; 17:1176934321999640.
  77. Tessema SK, Hathaway NJ, Teyssier NB, et al. Sensitive, Highly Multiplexed Sequencing of Microhaplotypes From the Plasmodium falciparum Heterozygome. J Infect Dis. 2022 Apr 1; 225(7):1227-1237.
  78. Teyssier NB, Chen A, Duarte EM, et al. Optimization of whole-genome sequencing of Plasmodium falciparum from low-density dried blood spot samples. Malar J. 2021; 20 116.
  79. Tichkule S, Myung Y, Naung MT, et al. VIVID: A Web Application for Variant Interpretation and Visualization in Multi-dimensional Analyses. Molecular Biology and Evolution, Volume 39, Issue 9, September 2022, msac196
  80. Tintó-Font E, Michel-Todó L, Russell TJ, et al. A heat-shock response regulated by the PfAP2-HS transcription factor protects human malaria parasites from febrile temperatures. Nat Microbiol. 2021 Sep;6(9):1163-1174.
  81. Turkiewicz A, Manko E, Sutherland CJ, et al. Genetic diversity of the Plasmodium falciparum GTP-cyclohydrolase 1, dihydrofolate reductase and dihydropteroate synthetase genes reveals new insights into sulfadoxine-pyrimethamine antimalarial drug resistance. PLoS Genet. 2020 Dec; 16(12) e1009268.
  82. Ukegbu CV, Giorgalli M, Tapanelli S, et al. PIMMS43 is required for malaria parasite immune evasion and sporogonic development in the mosquito vector. Proc Natl Acad Sci U S A. 2020 Mar 31; 117(13) 7363-7373.
  83. Uwimana A, Legrand E, Stokes BH, et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med. 2020; 26(10) 1602-1608.
  84. Valdivia HO, Villena FE, Lizewski SE, et al. Genomic surveillance of Plasmodium falciparum and Plasmodium vivax cases at the University Hospital in Tegucigalpa, Honduras. Sci Rep. 2020; 10 20975.
  85. van der Pluijm RW, Tripura R, Hoglund RM, et al. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial. Lancet. 2020;395(10233):1345-1360.
  86. Verity R, Aydemir O, Brazeau NF, et al. The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC. Nat Commun. 2020; 11 2107.
  87. Villena FE, Sanchez JF, Nolasco O, et al. Drug resistance and population structure of Plasmodium falciparum and Plasmodium vivax in the Peruvian Amazon. Sci Rep. 2022 Oct 1;12(1):16474.
  88. Wang K, Dagil R, Lavstsen T, et al. Cryo-EM reveals the architecture of placental malaria VAR2CSA and provides molecular insight into chondroitin sulfate binding. Nat Commun. 2021 May 19; 12(1):2956.
  89. Watson JA, Taylor AR, Ashley EA, et al. A cautionary note on the use of unsupervised machine learning algorithms to characterise malaria parasite population structure from genetic distance matrices. PLoS Genet. 2020 Oct; 16(10) e1009037.
  90. Watson OJ, Okell LC, Hellewell J, et al. Evaluating the Performance of Malaria Genetics for Inferring Changes in Transmission Intensity Using Transmission Modeling. Mol Biol Evol. 2021 Jan; 38(1) 274-289.
  91. Wicht KJ, Small-Saunders JL, Hagenah LM, et al. Mutant PfCRT Can Mediate Piperaquine Resistance in African Plasmodium falciparum With Reduced Fitness and Increased Susceptibility to Other Antimalarials. J Infect Dis. 2022 Sep 9:jiac365.
  92. Xiong A, Prakash P, Gao X, et al. K13-Mediated Reduced Susceptibility to Artemisinin in Plasmodium falciparum Is Overlaid on a Trait of Enhanced DNA Damage Repair. Cell Rep. 2020 Aug 4; 32(5) 107996.